Pipeline Programs↗
Distinct drugs in development (Preclinical–Phase 3)
Indications↗
Distinct diseases across all programs
Clinical Trials↗
All sponsored trials (all statuses)
Pipeline
By Phase
4 drugs in development
By Therapeutic Area
top 5
R&D Momentum
79/100
Pipeline Velocity
52/100
Trial Completion Rate
80/100
Pipeline Concentration
19/100
Pipeline Freshness
79/100
Strategic Signals
Activity
Last 14 days
Pediatric Influence of Cooling Duration on Efficacy in Cardiac Arrest Patients (P-ICECAP)
The Role of Circulating Meta-Inflammatory Monocytes in Adolescent Insulin Resistance
Clinical Performance of Alternative Preparation Designs for Chairside CAD/CAM Fabricated Advanced Lithium Disilicate EndoCrowns
Utilizing a SMART Intervention Design to Optimize Participant Adherence in Home-based Behavioral Interventions
Identification of Phenotypic Factors That Predict Success for Weight Loss and Long-term Weight Maintenance
Protocol for a Sequential Multiple-Assignment Randomized Trial to Optimize an Adaptive Intervention to Promote Evidence-based Management of Induction of Labor: the IGNITE-IOL Trial
Home Exercise And Resiliency Training (HEART) Club: A Virtual Care at Home Program to Reduce Frailty for Adults With Fontan Circulation
WE BEAT - HEART Club Fontan Wellness Project: A Virtual Resilience Promotion and Frailty Prevention Program
Artificial Intelligence for Proximal Caries Detection and Its Impact on Treatment Threshold: Randomized Trial
Behavioral Change Following Culturally Informed Biomarker Disclosure in Alzheimer's Disease
Intern Health Study 2026
Details
Company Overview
—
Mkt Cap
—
Revenue
—
Cash
Pipeline
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)